ART2BP

Across TCGA pan-cancer cohorts, ART2BP RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated ART2BP data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ART2BP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ART2BP expression acts as an unfavorable survival marker.

THCA, PAAD, and UCEC are the cancer types where ART2BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	III,IV	0.157	0.830	<.001	99	view →
PAAD	OS	Tertile	All	0.140	0.590	<.001	72	view →
UCEC	DFS	Tertile	All	0.769	0.902	.006	66	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	39	view →
KIRP	OS	Tertile	III,IV	0.247	0.809	.003	27	view →
LIHC	OS	Tertile	All	0.008	0.775	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

ART2BP–THCA (DFS)

Open the THCA breakdown →